If you are not sure if the website you would like to visit is secure, you can verify it here. Enter the website address of the page and see parts of its content and the thumbnail images on this site. None (if any) dangerous scripts on the referenced page will be executed. Additionally, if the selected site contains subpages, you can verify it (review) in batches containing 5 pages.
favicon.ico: resilience.com - Biomanufacturing CDMO | Biolog.

site address: resilience.com redirected to: resilience.com

site title: Biomanufacturing CDMO Biologics Drug Product Cell Therapy CDMO

Our opinion (on Saturday 11 July 2026 23:15:38 UTC):

GREEN status (no comments) - no comments
After content analysis of this website we propose the following hashtags:



Meta tags:
description=Resilience is a biomanufacturing CDMO improving access to complex medicines, with end-to-end solutions for safe & scalable biologics manufacturing.;

Headings (most frequently used words):

the, of, to, at, resilience, announcing, relocation, our, west, coast, headquarters, ohio, nothing, in, this, industry, ever, stays, same, so, we, ve, evolved, too, facilities, custom, solutions, fit, your, needs, earning, trust, one, dose, time, what, new, benefits, working, with, upcoming, events, contact, us, commercial, readiness, successful, inspections, contract, pharma, 2026, cphi, worldwide, cdmo, live, americas, biomanufacturing, world, summit,

Text of the page (most frequently used words):
and (90), the (61), resilience (60), biomanufacturing (47), release (43), press (42), #manufacturing (40), therapy (35), with (32), cell (32), 2023 (27), for (26), drug (26), development (26), news (24), product (23), 2024 (23), your (19), finish (19), biologics (18), partnerships (18), fill (18), sterile (15), webinar (15), 2025 (15), 2021 (14), demand (14), company (13), 2026 (12), technology (12), 2022 (12), announces (12), resources (12), november (11), february (11), may (11), therapies (11), process (11), january (11), gene (11), cdmo (10), from (10), transfer (10), facilities (10), tech (10), analytical (10), vaccines (10), our (9), future (9), next (9), march (9), financing (9), october (9), june (9), solutions (9), expansion (8), accelerate (8), partnership (8), presentation (8), scale (8), access (8), new (7), quality (7), capacity (7), million (7), july (7), medicines (7), capabilities (7), pharma (6), regulatory (6), through (6), strategic (6), team (6), science (6), announce (6), august (6), complex (6), december (6), west (6), culture (6), data (6), north (5), innovation (5), help (5), more (5), its (5), facility (5), how (5), technologies (5), year (5), ohio (5), substance (5), what (5), outsourced (5), update (5), supply (5), commercial (5), insights (5), media (5), coverage (5), speed (5), advanced (4), device (4), packaging (4), america (4), approach (4), time (4), you (4), expertise (4), proof (4), that (4), site (4), multi (4), video (4), based (4), resilient (4), success (4), aseptic (4), coast (4), can (4), clinical (4), clinic (4), car (4), blue (4), ash (4), long (4), term (4), strategy (4), relocation (4), headquarters (4), end (4), across (4), careers (4), national (3), boston (3), events (3), building (3), one (3), assembly (3), delivery (3), stage (3), gate (3), digital (3), built (3), medicine (3), biotech (3), april (3), government (3), canada (3), expand (3), alliance (3), develop (3), generation (3), are (3), manufacture (3), vaccine (3), philadelphia (3), collaboration (3), cancer (3), establish (3), astrazeneca (3), large (3), molecules (3), pad (3), center (3), challenges (3), idea (3), platform (3), focus (3), therapeutics (3), novel (3), allogeneic (3), chains (3), 825 (3), dar (3), blog (3), usfda (3), readiness (3), build (3), industry (3), cincinnati (3), articles (3), sprout (3), autologous (3), all (2), corporate (2), terms (2), safety (2), san (2), diego (2), contract (2), proven (2), expert (2), lead (2), transparency (2), control (2), commitment (2), thinking (2), discovery (2), three (2), move (2), than (2), 2020 (2), pandemic (2), transform (2), sanofi (2), plant (2), expands (2), acquisition (2), east (2), ology (2), bioservices (2), investment (2), improving (2), bio (2), meet (2), take (2), months (2), september (2), launch (2), companies (2), protein (2), department (2), defense (2), joint (2), venture (2), innovative (2), network (2), institute (2), deliver (2), partner (2), california (2), purchase (2), chester (2), does (2), funding (2), alachua (2), leading (2), pharmaceutical (2), nucleic (2), ahead (2), corporation (2), achieve (2), filling (2), into (2), high (2), their (2), viral (2), accelerating (2), timelines (2), appoints (2), marth (2), services (2), twins (2), improve (2), chain (2), white (2), paper (2), streamline (2), healthcare (2), artificial (2), intelligence (2), engineering (2), successful (2), bringing (2), forward (2), landscape (2), path (2), research (2), awards (2), annex (2), ngo (2), chief (2), officer (2), critical (2), key (2), executive (2), partners (2), support (2), day (2), advancing (2), innovations (2), trends (2), strength (2), complexity (2), performance (2), inspection (2), 100 (2), vials (2), pre (2), filled (2), syringes (2), each (2), molecule (2), bold (2), today (2), tomorrow (2), needs (2), sites (2), while (2), search (2), connect (2), scientific (2), webinars (2), toronto (2), leadership (2), auto (2), offerings (2), driven (2), edge (2), driving (2), breakthroughs (2), shaping (2), designed (2), 000 (2), specializing (2), start (2), unlock (2), full (2), just (2), vetted (2), llc, rights, reserved, cookie, settings, privacy, policy, compliance, service, inquiries, contact, world, summit, live, americas, milan, italy, cphi, worldwide, brunswick, upcoming, out, largest, most, injectable, operations, drive, safer, faster, smarter, project, backed, technical, advocacy, customer, centricity, risk, filings, real, management, system, gives, catalyst, exceptional, work, tandem, stages, defining, advantages, potential, breakthrough, get, when, engage, benefits, working, launches, change, raging, raises, 800m, aims, prepares, allston, but, not, city, tax, breaks, bags, genzyme, fireside, chat, rahul, signhvi, ceo, american, two, premier, stars, aligned, cash, reserve, bob, nelsen, plans, makeover, additions, upstart, bay, revolution, continues, receives, usd, 164, modernize, ontario, preparedness, bluebird, startups, top, vcs, say, poised, off, mrna, moderna, covid, joins, forces, children, hospital, create, impactful, harvard, university, five, incubate, advance, acquires, swiftscale, leader, free, synthesis, subsidiary, awarded, worth, 250, botulinum, neurotoxin, treatment, establishes, takeda, plasma, derived, business, unit, anderson, 625, series, bring, parker, immunotherapy, biotherapeutics, rare, conditions, becomes, resource, regenerative, establishing, honored, goldman, sachs, entrepreneurship, become, mainstream, option, equity, mubadala, biopharma, united, arab, emirates, signs, acids, looking, have, store, acid, approved, 410m, finance, master, banks, laying, foundation, final, leveraging, problem, solving, enters, labcorp, overcoming, obstacles, throughput, platforms, opening, lifera, saudi, arabia, early, phase, products, bridgebio, induced, pluripotent, stem, cells, ipscs, pluristyx, bill, president, aim, reduce, timeline, security, efficiency, meets, economy, power, single, use, chromatography, mab, purification, builds, lab, tracking, aws, model, present, 42nd, annual, morgan, conference, developing, containing, aluminum, adjuvants, taiwan, groundbreaking, disrupt, increase, capacities, optimize, using, velocity, guide, space, starburst, rebel, revised, microbial, strategies, campus, tour, vector, line, cho, manufacturability, susan, billings, secures, domestic, ingredients, steps, journey, appointment, william, rph, mba, parvus, pvt401, autoimmune, candidate, ibd, expedited, sample, report, hours, proud, cargo, whitepaper, short, cycle, rapid, omics, characterization, jobsohio, continued, interview, lives, reducing, costs, patient, navigating, evolving, cdmos, making, secure, integrated, systems, enhance, redefining, conversation, nicholas, kirian, clarity, sharpening, demanding, era, filter, scroll, ema, virtual, health, pfs, vial, approval, pai, cgmp, inspections, pass, rate, third, party, assessments, dedication, drives, everything, unwavering, comes, life, earning, trust, dose, photo, captured, training, environment, logistics, were, founded, straightforward, yet, purpose, broaden, protect, biopharmaceutical, against, disruption, heart, ensure, made, quickly, safely, sustainably, custom, fit, see, continental, spans, global, markets, serves, customers, asia, middle, expanded, strengths, keeping, sustainability, front, together, brilliant, minds, ight, first, nothing, this, ever, stays, same, evolved, too, read, northern, suburb, announcing, showcasing, cutting, sessions, experts, covering, scalable, analysis, gen, discoveries, inform, keep, stride, gmp, monoclonal, antibodies, recombinant, proteins, other, testing, ft², excellence, cartridges, 190, planned, include, visual, assemble, cold, storage, warehousing, indicates, commercially, licensed, modalities, experienced, leaders, join, mission, expanding, disrupters, welcome, here, flexibility, flexible, modular, approaches, overcome, concept, commercialization, audacious, agile, secondary, supplier, levels, empower, biologic, savings, days, ensuring, precision, scalability, step, nurtures, named, powered, trusted, ready, roll, skip, main, content,


Text of the page (random words):
trusted vetted and ready to roll named solutions for critical biomanufacturing needs each powered by the full strength speed and science of resilience sprout solutions for your next step in drug substance or fill finish sprout nurtures your molecule with transparency speed and partnership from day one auto t a vetted manufacturing platform to help your t cell based therapy achieve clinical readiness in just 12 months dar t autologous car t manufacturing in just 3 days accelerating access while ensuring precision and scalability idea to clinic empower your biologic s path to clinic and deliver your team a 30 time savings from start to finish build your resilience secondary supplier with three levels of readiness full access to quality supply chain and commercial support on your terms expertise audacious agile advanced we can help you overcome complexity and accelerate your novel therapy from concept to commercialization biologics platform based approaches designed to streamline development and unlock commercial success cell therapy flexible modular solutions for autologous and allogeneic therapies manufacturing end to end development scale up and tech transfer built for speed flexibility and scale company industry disrupters welcome here future proof your discovery with a cdmo partner built to scale innovation and unlock what s next in biomanufacturing careers join a mission driven team expanding access through science and manufacturing leadership team experienced leaders driving innovation resilient supply chains and access to medicines partnerships bold breakthroughs start with partnerships shaping the future of healthcare facilities across north america resilience sites are building the future of medicine advancing complex modalities with leading edge development and manufacturing capabilities indicates commercially licensed facility blue ash hq 190 000 ft 2 packaging facility with a planned expansion to include visual inspection device assemble and cold storage warehousing cincinnati specializing in drug product manufacturing device assembly and packaging with fill finish capabilities for vials cartridges and pre filled syringes philadelphia 85 000 ft² center of excellence specializing in development manufacturing and release testing of autologous and allogeneic cell therapies toronto pad gmp manufacturing capabilities for monoclonal antibodies recombinant proteins and other complex molecules resources keep your science in stride insights data and discoveries designed to inform and accelerate your next move blog biomanufacturing breakthroughs industry insights and company news shaping the future of advanced therapeutics insights expert analysis on key trends challenges and technologies driving next gen biomanufacturing forward webinars on demand sessions with resilience experts and partners covering science strategy and scalable solutions scientific articles research driven articles showcasing cutting edge data and innovations across biologics cell therapy and gene therapy search connect offerings sprout solutions auto t dar t idea to clinic build your resilience expertise biologics cell therapy manufacturing company careers leadership team partnerships facilities blue ash hq cincinnati philadelphia toronto resources blog insights webinars scientific articles news events careers connect search announcing the relocation of our west coast headquarters to ohio resilience announces the relocation of its corporate headquarters from san diego california to blue ash ohio a northern suburb of cincinnati and expansion of its sterile manufacturing capabilities read the press release nothing in this industry ever stays the same so we ve evolved too we ve expanded our strengths while keeping quality speed and sustainability front and center to build a more resilient tomorrow today resilience is bringing together brilliant minds in science and engineering with access to advanced technologies and r ight first time performance at scale facilities resilience is north america based with facilities across the continental us and canada our regulatory expertise spans across global markets and serves customers in the eu asia the middle east and north america see our sites custom solutions to fit your needs we were founded with a straightforward yet bold purpose to broaden access to complex medicines and to protect biopharmaceutical supply chains against disruption at the heart of our approach is a network of high tech end to end drug substance and drug product manufacturing solutions that can help ensure the medicines of today and tomorrow can be made quickly safely sustainably and at scale large molecule biologics development manufacturing cell therapy development manufacturing aseptic drug product manufacturing device assembly packaging logistics photo captured in aseptic training environment earning trust one dose at a time our dedication to quality drives everything we do our unwavering commitment comes to life through the delivery of more than 100 million vials and pre filled syringes each year commercial readiness 100 pass rate for third party and eu annex 1 assessments successful inspections usfda cgmp usfda pai usfda pfs vial approval health canada ema virtual inspection what s new at resilience scroll filter all blog news june 18 2026 resilience announces relocation of west coast headquarters to ohio and expansion of sterile manufacturing capabilities facilities in the news may 14 2026 from complexity to clarity sharpening focus for long term performance in a more demanding cdmo era company culture in the news november 20 2025 resilience announces long term financing of up to 825 million to accelerate cdmo strategy press release biomanufacturing drug product sterile fill finish in the news financing november 20 2025 redefining car t speed and strength with dar t a conversation with nicholas kirian cell therapy technology resources october 29 2025 resilience announces long term financing of up to 825 million to accelerate cdmo strategy press release biomanufacturing drug product sterile fill finish in the news financing july 11 2025 how integrated data systems enhance clinical development and manufacturing biomanufacturing tech transfer technology development june 27 2025 cdmos are making their supply chains more resilient secure biomanufacturing in the news development june 05 2025 navigating the evolving landscape of fill finish trends challenges and what s ahead biomanufacturing drug product may 08 2025 on demand webinar fill finish services outsourced pharma capacity update biomanufacturing drug product sterile fill finish webinar may 06 2025 cell therapy innovations reducing costs to improve patient access cell therapy biomanufacturing march 28 2025 executive interview advancing therapies that transform lives company culture march 26 2025 resilience and jobsohio announce continued partnership and expansion in blue ash press release biomanufacturing drug product in the news partnerships january 30 2025 presentation rapid multi omics cell therapy characterization and qc cell therapy technology presentation resources january 29 2025 whitepaper 3 day short cycle car t manufacturing process cell therapy technology white paper resources january 15 2025 resilience is proud to support cargo therapeutics novel allogeneic car t cell therapy press release in the news media coverage january 14 2025 presentation expedited cell therapy qc sample in to qc report in 48 hours cell therapy technology presentation resources january 08 2025 resilience partners with parvus therapeutics for development and manufacturing of pvt401 a novel autoimmune drug candidate for ibd press release in the news media coverage december 05 2024 resilience announces appointment of william s marth rph mba as chief executive officer press release company culture in the news media coverage november 05 2024 on demand webinar outsourced pharma capacity update drug substance biologics facilities webinar presentation drug substance october 28 2024 key steps in the vaccine scale up journey vaccines regulatory october 03 2024 resilience secures funding to expand domestic manufacturing for critical pharmaceutical ingredients press release biomanufacturing in the news media coverage government ngo september 30 2024 resilience appoints dr susan billings chief commercial officer press release company culture in the news media coverage july 10 2024 boston ma process analytical development and manufacturing facility vaccines biologics facilities gene therapy process and analytical development resources july 01 2024 on demand webinar outsourced pharma capacity update fill finish drug product sterile fill finish june 27 2024 on demand presentation improving cell line development in cho with a focus on product manufacturability biologics presentation resources june 27 2024 meet the team viral vector development manufacturing gene therapy biomanufacturing tech transfer company culture process and analytical development june 05 2024 alachua campus tour video government ngo may 02 2024 revised annex 1 and the focus on microbial control strategies biomanufacturing drug product regulatory sterile fill finish resources april 25 2024 starburst data rebel awards data product of the year in the news awards technology march 25 2024 building velocity into fill finish timelines your guide to quality and regulatory success in the cdmo space biomanufacturing drug product tech transfer sterile fill finish resources march 07 2024 on demand webinar outsourced pharma capacity update 2024 large molecules vaccines biologics facilities biomanufacturing drug product tech transfer process and analytical development february 23 2024 on demand webinar optimize research and delivery of complex medicines using data insights webinar partnerships technology february 20 2024 resilience expands clinical and commercial drug product manufacturing capabilities and capacities press release in the news partnerships february 19 2024 scale your vaccine development with path to pad vaccines process and analytical development february 13 2024 how resilience is bringing forward thinking to disrupt the biomanufacturing landscape to increase access to medicines company culture february 05 2024 national resilience and taiwan bio manufacturing corporation announce groundbreaking partnership in biomanufacturing innovation press release in the news partnerships january 11 2024 successful development and manufacturing of vaccines containing aluminum adjuvants vaccines sterile fill finish january 04 2024 developing new medicines through artificial intelligence technology artificial intelligence protein engineering january 04 2024 resilience to present at the 42nd annual j p morgan healthcare conference press release in the news december 21 2023 the stage gate model a proven approach to streamline biomanufacturing tech transfer technology white paper resources december 20 2023 resilience builds lab supply chain tracking platform on aws biomanufacturing partnerships technology december 12 2023 on demand video efficiency meets economy the power of single use chromatography in mab purification biologics december 11 2023 resilience announces expansion in west chester press release in the news partnerships november 30 2023 how digital twins help improve biomanufacturing quality and security digital twins technology november 17 2023 on demand video idea to clinic aim to reduce your manufacturing timeline by 30 biologics biomanufacturing november 07 2023 resilience appoints bill marth as president of services press release partnerships october 26 2023 accelerating clinical timelines of induced pluripotent stem cells ipscs with pluristyx cell therapy biomanufacturing in the news partnerships october 03 2023 bridgebio and resilience announce strategic multi year partnership press release partnerships august 29 2023 the challenges and solutions for viral products vaccines biomanufacturing august 28 2023 how early phase companies can future proof their cell therapies cell therapy process and analytical development august 28 2023 resilience announces joint venture with lifera in saudi arabia press release partnerships july 13 2023 opening of resilience s west coast cell therapy pad center cell therapy biomanufacturing in the news july 12 2023 on demand webinar high throughput process analytical platforms to accelerate gene therapy scale up gene therapy process and analytical development july 05 2023 overcoming obstacles in gene therapy manufacturing gene therapy biomanufacturing may 23 2023 on demand webinar future proof your aseptic filling webinar may 16 2023 resilience enters into strategic collaboration with labcorp to accelerate cell and gene therapies cell therapy gene therapy biomanufacturing may 11 2023 problem solving for aseptic filling drug product sterile fill finish may 08 2023 on demand webinar outsourced pharma capacity update large molecules vaccines biologics facilities biomanufacturing drug product tech transfer process and analytical development may 04 2023 leveraging partnerships to achieve cell therapy success cell therapy biomanufacturing april 03 2023 master cell banks laying the foundation to final product success gene therapy biomanufacturing march 24 2023 resilience approved for 410m financing from the department of defense in partnership with the development finance corporation to establish resilient biomanufacturing capacity press release financing march 23 2023 looking ahead what does the future have in store for nucleic acid based therapies nucleic acids february 16 2023 resilience signs multi year strategic biomanufacturing partnership with leading pharmaceutical company press release january 25 2023 alachua biomanufacturing expansion video vaccines biologics gene therapy biomanufacturing drug product tech transfer sterile fill finish january 10 2023 resilience announces equity investment from mubadala and funding of new biopharma manufacturing facility in the united arab emirates press release january 03 2023 resilience to establish biomanufacturing partnership with astrazeneca and purchase manufacturing site vaccines biologics biomanufacturing sterile fill finish november 29 2022 cell therapy what does it take to become a mainstream option cell therapy biomanufacturing resources november 29 2022 on demand drug substance manufacturing and drug product fill finish solutions presentation biologics biomanufacturing drug product tech transfer sterile fill finish process and analytical development webinar november 29 2022 resilience to establish a biomanufacturing partnership with astrazeneca and purchase astrazeneca s manufacturing site in west chester ohio press release october 12 2022 national resilience honored by goldman sachs for entrepreneurship press release october 05 2022 on demand webinar establishing a stage gate approach to biomanufacturing webinar august 23 2022 resilience becomes biomanufactu...
Thumbnail images (randomly selected): * Images may be subject to copyright.GREEN status (no comments)
  • Resilience

Verified site has: 125 subpage(s). Do you want to verify them? Verify pages:

1-5 6-10 11-15 16-20 21-25 26-30 31-35 36-40 41-45 46-50
51-55 56-60 61-65 66-70 71-75 76-80 81-85 86-90 91-95 96-100
101-105 106-110 111-115 116-120 121-125


Top 50 hastags from of all verified websites.

Supplementary Information (add-on for SEO geeks)*- See more on header.verify-www.com

Header

HTTP/1.1 301 Moved Permanently
Date Sat, 11 Jul 2026 23:15:38 GMT
Content-Length 0
Connection close
Location htt????/resilience.com/
set-cookie __cf_bm=SoBKfTZshE7zkCXrHHPCs0Ld.URElrMCRsiPXhxZbmA-1783811738.026828-1.0.1.1-1M8aAmnhfpsdJlI0UsIDM9NRH4MwwXXu_TlbqeC3PJY56tX.fCipwGTgVeZO5pVcwQ4Yheb9Mn0WFxEskpuBzYtbNemU3GXA1rLdrJtldEeYy5F3D.kf_MkIA4a3AYB8; HttpOnly; Path=/; Domain=resilience.com; Expires=Sat, 11 Jul 2026 23:45:38 GMT
set-cookie _cfuvid=6Wwoz.zVe65FhXqxrLIioC0KxfU2dpfLiJC0Nk8FWdA-1783811738.026828-1.0.1.1-mGWF5_2tqMf3GW5dGeQBo3eyKxcO_.93R2J0wdnsyg4; HttpOnly; SameSite=None; Secure; Path=/; Domain=resilience.com
Cache-Control s-maxage=3600,max-age=120
X-Hs-Https-Only worker
x-hs-cfworker-meta resolver : HttpsRedirectResolver
x-hs-portal-id 20797991
Vary accept-encoding
Report-To group : cf-nel , max_age :604800, endpoints :[ url : htt????/a.nel.cloudflare.com/report/v4?s=b17NhtGoaw99P%2FK4nvk7XVeo3rprSeEddNo1VvOOGPyHpaNu%2FsIkZvYIk8CVXq5Dyj1v58rZ3Pt7vbgwkRItDghM9yDomzNWmYl8LlZpOWkPCuom1%2BAZOQMdIczQISxu ]
Nel report_to : cf-nel , success_fraction :0.01, max_age :604800
Server cloudflare
CF-RAY a19b82e2ab209fc9-AMS
alt-svc h3= :443 ; ma=86400
HTTP/2 200
date Sat, 11 Jul 2026 23:15:38 GMT
content-type text/html; charset=UTF-8
set-cookie __cf_bm=GvfEE2VzeBkS88Yto.u8U_7JP3dBA1P9_AU.4y1HYZM-1783811738.0922246-1.0.1.1-otg0zZZ5ifHIE.mJHjacSd0h4105MEUvf3bRUwzCr36QvbzwIpuCEVepnBdAFSEVP1DvsrSu8hi.SNBz2lq6nTX1EuWYV1U8cWAzfz9V1exU9TCbh5a0O4frS7QmDlgX; HttpOnly; SameSite=None; Secure; Path=/; Domain=resilience.com; Expires=Sat, 11 Jul 2026 23:45:38 GMT
set-cookie _cfuvid=DWk7eHK9ZrphS6soXD7skOVl_ZGze__o3P94HI4qlRI-1783811738.0922246-1.0.1.1-F18yCCoQ0O7kvIuPU7uf08CzCeHMQKhdvmrysu1opaM; HttpOnly; SameSite=None; Secure; Path=/; Domain=resilience.com
cache-control no-store, no-cache, must-revalidate
last-modified Sat, 11 Jul 2026 02:07:22 GMT
link <htt????/cdnjs.cloudflare.com/ajax/libs/font-awesome/6.7.2/css/all.min.css>; rel=preload; as=style,<htt????/resilience.com/hubfs/RESI-24-003d%203DKA%20_%2008%20DS_Pesrp01%201-2-1.png>; rel=preload; as=image,<htt????/resilience.com/hubfs/hub_generated/template_assets/1/211871751171/1781790342978/template_underline_grid_richtext.min.css>; rel=preload; as=style,<htt????/resilience.com/hubfs/hub_generated/template_assets/1/211871763591/1781790338587/template_underline_grid.min.css>; rel=preload; as=style,<htt????/resilience.com/hubfs/hub_generated/template_assets/1/211871763989/1781790340246/template_absolute_image.min.css>; rel=preload; as=style,<htt????/cdn.jsdelivr.net/npm/swiper@11/swiper-bundle.min.css>; rel=preload; as=style,<htt????/resilience.com/hubfs/hub_generated/template_assets/1/211816390958/1781790339043/template_blog_posts_slider.min.css>; rel=preload; as=style
strict-transport-security max-age=31536000
content-security-policy upgrade-insecure-requests
edge-cache-tag CT-208835483143,CG-20797991,P-20797991,CW-182845648030,CW-188871411988,CW-188871700797,CW-188872273843,CW-188872273925,CW-188877972634,CW-188900061715,CW-188924559266,CW-188980425099,CW-189206119977,CW-189508966315,CW-189847541122,CW-189910204200,CW-190977916766,CW-191021164447,CW-198152701335,CW-202786465423,CW-211880973955,DB-103941719,DB-117295906,E-180445209106,E-180445209111,E-180445209153,E-180445846038,E-180446148957,E-188903271175,E-188903503655,E-188916310607,E-188916310633,E-188916310639,E-188917590666,E-188963718782,E-198085934703,E-198086043814,E-211768287010,E-211769752717,E-211816103224,E-211816390958,E-211816392240,E-211871725142,E-211871751171,E-211871751204,E-211871763591,E-211871763989,RA-180445209105,RA-213652427882,PGS-ALL,SW-4,B-109355290646,B-89015279678,B-98940880725,GC-188901050279,GC-188901050282,GC-190132272501,GC-198646688375,TS-180445846035
referrer-policy no-referrer-when-downgrade
x-hs-cf-cache-status HIT
x-hs-cache-config BrowserCache-5s-EdgeCache-0s
x-hs-cache-control s-maxage=36000, max-age=0
x-hs-content-id 208835483143
x-hs-hub-id 20797991
x-hs-prerendered Sat, 11 Jul 2026 02:07:22 GMT
x-hs-cfworker-meta contentType : SITE_PAGE , resolver : PreRenderedContentResolver
x-hs-portal-id 20797991
vary accept-encoding
report-to group : cf-nel , max_age :604800, endpoints :[ url : htt????/a.nel.cloudflare.com/report/v4?s=VuBh2SSC8aPgqsB0Oq%2B08BRQReXo8fpW41IKKLyqwYy5AG67wZrn%2BlfvlThdXR32kuf%2Bdfnyv1DaWrKEckkB0poN1U2Gqj2kD5X6FcUCAjf9jWfgrJv0QiWmN7RyBz90 ]
nel report_to : cf-nel , success_fraction :0.01, max_age :604800
content-encoding gzip
server cloudflare
cf-ray a19b82e31db84e96-AMS
alt-svc h3= :443 ; ma=86400

Meta Tags

title="Biomanufacturing CDMO | Biologics | Drug Product | Cell Therapy CDMO"
charset="utf-8"
name="viewport" content="width=device-width, initial-scale=1.0"
name="google-site-verification" content="nmzP5qMV2ubfT3weBoOo4YEEmnb_OifuruKQCKSBLGU"
name="description" content="Resilience is a biomanufacturing CDMO improving access to complex medicines, with end-to-end solutions for safe & scalable biologics manufacturing."
name="theme-color" content="#000000"
name="generator" content="HubSpot"
name="viewport" content="width=device-width, initial-scale=1"
property="og:description" content="Resilience is a biomanufacturing CDMO improving access to complex medicines, with end-to-end solutions for safe & scalable biologics manufacturing."
property="og:title" content="Biomanufacturing CDMO | Biologics | Drug Product | Cell Therapy CDMO"
name="twitter:description" content="Resilience is a biomanufacturing CDMO improving access to complex medicines, with end-to-end solutions for safe & scalable biologics manufacturing."
name="twitter:title" content="Biomanufacturing CDMO | Biologics | Drug Product | Cell Therapy CDMO"
property="og:image" content="htt????/resilience.com/hubfs/DS%20Key%20Art%20-%20DripCampaign%201%20-%20Header-1.png"
property="og:image:width" content="1845"
property="og:image:height" content="1035"
name="twitter:image" content="htt????/resilience.com/hubfs/DS%20Key%20Art%20-%20DripCampaign%201%20-%20Header-1.png"
property="og:url" content="htt????/resilience.com"
name="twitter:card" content="summary_large_image"
http-equiv="content-language" content="en"

Load Info

page size43261
load time (s)0.188559
redirect count1
speed download230111
server IP 199.60.103.92
* all occurrences of the string "http://" have been changed to "htt???/"